Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Casirivimab+Imdevimab with Moderna mRNA-1273 vaccine in healthy volunteers
NCT04852978Phase 2Completed
- Sponsor
- Regeneron Pharmaceuticals
- Start
- Apr 2021
- Primary completion
- Nov 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of casirivimab + imdevimab in coronavirus disease 2019 (COVID-19), sponsored by Regeneron Pharmaceuticals. Started Apr 2021; status: completed.
02
Drugs
casirivimab + imdevimab
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04852978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04852978.